
Ranexa Extended-Release Tablet 500 mg (Ranolazine)
500mg
Tablet · Prescription medication
Korea Menarini Co., Ltd.
Ranolazine is a cardiac blood flow improving ingredient used in the treatment of chronic stable angina.
MFDS ingredient code M278248
Ranolazine is a medication that helps regulate the metabolism of cardiac muscle cells and is used in the treatment of chronic stable angina. This ingredient improves oxygen supply to the heart, contributing to the relief of chest pain.
Ranolazine enhances the energy efficiency of cardiac muscle by regulating the balance of sodium and calcium ions within heart cells. This reduction in chest pain occurs when there is insufficient oxygen supply to the heart.
Approved uses differ by product. Check each product's information for its actual use.
Unlike traditional vasodilators, ranolazine acts directly on cardiac metabolism to reduce oxygen consumption. This distinguishing advantage is that it does not significantly affect blood pressure or heart rate.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
3 total

500mg
Tablet · Prescription medication
Korea Menarini Co., Ltd.

375mg
Tablet · Prescription medication
Korea Menarini Co., Ltd.

750mg
Tablet · Prescription medication
Korea Menarini Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.